Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for nasal dorsum augmentation
TCTR20190907001Phase 4Completed
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A, sponsored by None. Primary endpoint: Volume difference of nasal dorsum. Started Sep 2019; status: completed.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on TCTR20190907001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190907001.